EDITORIAL article

Front. Public Health, 24 April 2025

Sec. Children and Health

Volume 13 - 2025 | https://doi.org/10.3389/fpubh.2025.1585347

This article is part of the Research TopicThe Impact of Exposure to Environmental Chemicals, Pharmaceuticals and Particles via Human Breast Milk: A Focus on Health Effects and Underlying MechanismsView all 8 articles

Editorial: The impact of exposure to environmental chemicals, pharmaceuticals and particles via human breast milk: a focus on health effects and underlying mechanisms

  • 1Centre for Environmental Sciences, Hasselt University, Diepenbeek, Belgium
  • 2Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Center for Neurosciences, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Jette, Belgium

Introduction

Breastfeeding is widely recognized as the optimal source of nutrition for ensuring the health and wellbeing of infants, providing essential nutrients and antibodies that strengthen their immune system and support neurodevelopment (13). However, the presence of environmental pollutants and pharmaceuticals in human milk could raise concerns regarding potential adverse health effects on nursing infants, as it has been shown that both breastfeeding mothers and healthcare providers are concerned about the transfer of these exogenous substances in milk (4). This Research Topic aimed to explore the impact of exposure to various environmental chemicals, pharmaceuticals, and particles through human milk, focusing on understanding their biological effects on children and adolescents. The accepted studies in this Research Topic comprise a mini review, two brief research reports, and four original research papers, providing insights into the complexities of maternal transfer of these substances and emphasizing the need for continued research and funding to safeguard maternal and infant health.

Contribution to the field

Naspolini et al. investigated the relation between metals (i.e., As, Pb, Hg, and Cd) in human milk and neurodevelopmental outcomes in infants between three and 16 months old, assessed with the Bayley-Scales of Infant and Toddler Development (Bayley-III). All metals, except Cd, were detected in breast milk and infants exposed to Pb had lower language development trajectories than non-exposed infants.

Five studies focused on pharmaceuticals in human milk. The review by De Hondt et al. examined the transfer of Attention Deficit/Hyperactivity Disorder (ADHD) medications into human milk and their potential impact on nursing infants. This review highlights the lack of methods to monitor multiple ADHD medications and the limited research on their quantification. This article emphasizes the need for further research to better understand medication transfer and develop clinical guidelines for mothers with ADHD during lactation. The case report by Van Neste et al. examined the transfer of monomethyl fumarate (MMF), the active metabolite of dimethyl fumarate (DMF), into human milk in a postpartum woman treated for multiple sclerosis. MMF concentrations varied widely in milk samples, but estimated infant exposure remained low, with relative infant doses (RIDs) between 0.16% and 0.22%. Combined with two previous cases (5), these findings suggest minimal MMF transfer to breast milk, though further research is needed to assess infant exposure and safety. Falconi et al. assessed the transfer of sacubitril/valsartan into human milk and the potential risk to infants. Valsartan was undetectable in all milk samples, while sacubitril and its active metabolite LBQ657 were present at low concentrations, with a combined RID of < 0.25%, well below the safety threshold of 10%. These findings suggest minimal exposure through breastfeeding, indicating a low risk to infants. Naidoo et al. investigated the impact of prenatal exposure to tenofovir diphosphate (TFV-DP) containing pre-exposure prophylaxis (PrEP) on growth metrics in HIV-unexposed, breastfed African infants and found no significant differences in weight, length, or head circumference Z-scores over 18 months. These findings suggest that prenatal exposure to TFV-DP does not affect early childhood growth. While previous studies specifically examine pharmaceuticals in human milk, mothers can be worried about the transfer of vaccine particles into milk. Despite a systematic review reporting no severe COVID-19 vaccine-related adverse effects in either mothers or nursing infants and no significant transfer of vaccine components into breast milk (6), vaccine hesitancy among breastfeeding women seems to remain high. Simsekoglu et al. examined COVID-19 vaccine hesitancy and attitudes among pregnant and breastfeeding women in Turkey. While participants showed a high level of vaccine hesitation, their overall attitude toward vaccination was positive. Factors such as working status, influenza vaccination history, smoking, and chronic disease influenced hesitancy and attitudes, highlighting the need for targeted strategies to address concerns in future pandemics (7).

Lastly, one study focused on environmental particles in human milk. Cosemans et al. showed for the first time that traffic-related particulate matter, such as black carbon particles, was detected in human milk and found an association with ambient air pollution concentrations at the maternal residential address. This study reported a novel pathway through which these particles can directly enter the infant's system, in addition to being exposed via inhalation. It has been previously established that prenatal exposure to particulate matter is linked to health outcomes in children, such as neurodevelopment (8), kidney function (9), and growth trajectories (10). However, the impact of this new route of exposure via human milk remains unknown and needs further investigation.

Conclusion

The findings presented in this Research Topic underscore the necessity for heightened awareness and further investigation into the presence and effects of environmental pollutants and pharmaceuticals in human milk. Regarding pharmaceuticals, the studies highlighted methodological challenges, and for certain pharmaceuticals, a low level of exposure was detected. In contrast, in the context of environmental exposures, the detection of environmental particles in human milk presents entirely new challenges that warrant further investigation. Understanding exposure pathways and their implications for infant health is essential for developing effective public health policies and clinical guidelines. By continuing to explore these critical issues, we can alleviate any concerns families may have regarding the safety of their infants.

Author contributions

CC: Writing – original draft, Writing – review & editing. ET: Writing – review & editing. MP: Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. Charlotte Cosemans was financially supported by the Research Foundation Flanders (FWO; 1249025N).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Generative AI statement

The author(s) declare that Gen AI was used in the creation of this manuscript. During the preparation of this work, the author(s) used ChatGPT in order to improve the language and readability of the manuscript. After using this tool, the author(s) reviewed and edited the content as needed and take full responsibility for the content of the publication.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Cosemans C, Nawrot TS, Janssen BG, Vriens A, Smeets K, Baeyens W, et al. Breastfeeding predicts blood mitochondrial DNA content in adolescents. Sci Rep. (2020) 10:387. doi: 10.1038/s41598-019-57276-z

PubMed Abstract | Crossref Full Text | Google Scholar

2. Horta BL, Victora CG. Long-Term Effects of Breastfeeding: a Systematic Review. (2013). Available online at: https://iris.who.int/handle/10665/79198

Google Scholar

3. Horta BL, de Lima NP. Breastfeeding and type 2 diabetes: systematic review and meta-analysis. Curr Diab Rep. (2019) 19:1. doi: 10.1007/s11892-019-1121-x

PubMed Abstract | Crossref Full Text | Google Scholar

4. De Hondt L, Gorsen SL, Verburgh P, De Paepe K, Muyldermans J, Tommelein E. Health care providers' perspective and knowledge about peri-surgical medication and practices in breastfeeding women. Int J Environ Res Public Health. (2023) 20:3379. doi: 10.3390/ijerph20043379

PubMed Abstract | Crossref Full Text | Google Scholar

5. Ciplea AI, Datta P, Rewers-Felkins K, Baker T, Gold R, Hale TW, et al. Dimethyl fumarate transfer into human milk. Ther Adv Neurol Disord. (2020) 13:1756286420968414. doi: 10.1177/1756286420968414

PubMed Abstract | Crossref Full Text | Google Scholar

6. Muyldermans J, De Weerdt L, De Brabandere L, Maertens K, Tommelein E. The effects of COVID-19 vaccination on lactating women: a systematic review of the literature. Front Immunol. (2022) 13:852928. doi: 10.3389/fimmu.2022.852928

PubMed Abstract | Crossref Full Text | Google Scholar

7. Abu-Raya B, Madhi SA, Omer SB, Amirthalingam G, Giles ML, Flanagan KL, et al. Global perspectives on immunization against SARS-CoV-2 during pregnancy and priorities for future research: an international consensus paper from the world association of infectious diseases and immunological disorders. Front Immunol. (2021) 12:808064. doi: 10.3389/fimmu.2021.808064

PubMed Abstract | Crossref Full Text | Google Scholar

8. Cosemans C, Madhloum N, Sleurs H, Alfano R, Verheyen L, Wang C, et al. Prenatal particulate matter exposure is linked with neurobehavioural development in early life. Environm Res. (2024) 252:118879. doi: 10.1016/j.envres.2024.118879

PubMed Abstract | Crossref Full Text | Google Scholar

9. Rasking L, Van Pee T, Vangeneugden M, Renaers E, Wang C, Penders J, et al. Newborn glomerular function and gestational particulate air pollution. EBioMedicine. (2024) 107:105253. doi: 10.1016/j.ebiom.2024.105253

PubMed Abstract | Crossref Full Text | Google Scholar

10. Cosemans C, Wang C, Alfano R, Martens DS, Sleurs H, Dockx Y, et al. In utero particulate matter exposure in association with newborn mitochondrial ND4L(10550A>G) heteroplasmy and its role in overweight during early childhood. Environm Health. (2022) 21:88. doi: 10.1186/s12940-022-00899-z

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: breastfeeding, environmental pollutants, pharmaceuticals, human milk (HM), particles

Citation: Cosemans C, Tommelein E and Plusquin M (2025) Editorial: The impact of exposure to environmental chemicals, pharmaceuticals and particles via human breast milk: a focus on health effects and underlying mechanisms. Front. Public Health 13:1585347. doi: 10.3389/fpubh.2025.1585347

Received: 28 February 2025; Accepted: 16 April 2025;
Published: 24 April 2025.

Edited and reviewed by: Tim S. Nawrot, University of Hasselt, Belgium

Copyright © 2025 Cosemans, Tommelein and Plusquin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Charlotte Cosemans, Y2hhcmxvdHRlLmNvc2VtYW5zQHVoYXNzZWx0LmJl

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.